NOTICE: Labnodes will be unavailable on Sunday March 4th for scheduled maintenance from 6-11AM central time.
  1. Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism. Zhao J, Matthies DS, Botzolakis EJ, Macdonald RL, Blakely RD, Hedera P (2008) J Neurosci 28(51): 13938-51
    › Primary publication · 19091982 (PubMed) · PMC2660329 (PubMed Central)
  2. Going with the flow: trafficking-dependent and -independent regulation of serotonin transport. Steiner JA, Carneiro AM, Blakely RD (2008) Traffic 9(9): 1393-402
    › Primary publication · 18445122 (PubMed) · PMC2773847 (PubMed Central)
  3. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder. Kim CH, Waldman ID, Blakely RD, Kim KS (2008) Ann N Y Acad Sci : 256-60
    › Primary publication · 18591486 (PubMed)
  4. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Carvelli L, Blakely RD, DeFelice LJ (2008) Proc Natl Acad Sci U S A 105(37): 14192-7
    › Primary publication · 18768815 (PubMed) · PMC2528871 (PubMed Central)
  5. Distinctions between dopamine transporter antagonists could be just around the bend. Henry LK, Blakely RD (2008) Mol Pharmacol 73(3): 616-8
    › Primary publication · 18156312 (PubMed)
  6. Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75. Hoard JL, Hoover DB, Mabe AM, Blakely RD, Feng N, Paolocci N (2008) Neuroscience 156(1): 129-42
    › Primary publication · 18674600 (PubMed) · PMC2640831 (PubMed Central)
  7. Anomalous dopamine release associated with a human dopamine transporter coding variant. Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD (2008) J Neurosci 28(28): 7040-6
    › Primary publication · 18614672 (PubMed) · PMC2573963 (PubMed Central)
  8. Aberrant trafficking of the high-affinity choline transporter in AP-3-deficient mice. Misawa H, Fujigaya H, Nishimura T, Moriwaki Y, Okuda T, Kawashima K, Nakata K, Ruggiero AM, Blakely RD, Nakatsu F, Ohno H (2008) Eur J Neurosci 27(12): 3109-17
    › Primary publication · 18554297 (PubMed)
  9. Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. McDonald PW, Hardie SL, Jessen TN, Carvelli L, Matthies DS, Blakely RD (2007) J Neurosci 27(51): 14216-27
    › Primary publication · 18094261 (PubMed)
  10. The functional impact of SLC6 transporter genetic variation. Hahn MK, Blakely RD (2007) Annu Rev Pharmacol Toxicol : 401-41
    › Primary publication · 17067279 (PubMed)